Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells
Open Access
- 4 June 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogenesis
- Vol. 1 (6), e12
- https://doi.org/10.1038/oncsis.2012.12
Abstract
Radioresistance, which is a major cause of failure of radiotherapy (RT), is proposed as one of the intrinsic characteristics of cancer stem cells (CSCs) whose unique DNA damage response (DDR), efficient DNA repair and resistance to apoptosis are thought to confer the phenotype. We have isolated surviving CSCs by exposure to long-term fractionated radiation for 82 days from HepG2 and A172 cells (82FR-31NR cells). 82FR-31NR cells exhibited CSC properties, such as high expression of CSC marker CD133 and the ABC transporters (MDR1 and BCRP1), and high tumorigenic potential after transplantation into nude mice. The advantage of our isolated CSCs is that they can proliferate in as the same growth medium as that of parental cells without loss of CSC properties. Therefore, we can analyze DDR of non-stem cells and CSCs without any influences caused by different culture conditions. 82FR-31NR cells showed efficient DNA repair of radiation-induced DNA damage and radioresistance with activation of the AKT/cyclin D1 survival signaling pathway. In contrast, DNA damage persisted for a long time after irradiation in parental cells compared with isolated CSCs. Persisted DNA damage induced apoptosis in parental cells without activation of the AKT/cyclin D1 pathway. Therefore, inhibition of the AKT/cyclin D1 pathway by an AKT inhibitor, API-2, or cyclin D1 siRNA resulted in a loss of efficient DNA repair and radiosensitization of 82FR-31NR cells. Furthermore, knockdown of Cdk4 by its siRNA or a Cdk4 inhibitor was sufficient to suppress radioresistance of CSCs. In this study, we present a newly discovered DDR regarding the AKT/cyclin D1/Cdk4 pathway in response to radiation in CSCs. Combination of fractionated RT and reagents targeting the AKT/cyclin D1/Cdk4 pathway to eradicate CSCs would be effective therapeutic modality.Keywords
This publication has 39 references indexed in Scilit:
- A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancersNature, 2011
- Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3Acta Biochimica et Biophysica Sinica, 2010
- Targeting Stem Cells-Clinical Implications for Cancer TherapyCurrent Stem Cell Research & Therapy, 2009
- Bloom's Syndrome Helicase and Mus81 are Required to Induce Transient Double-strand DNA Breaks in Response to DNA Replication StressJournal of Molecular Biology, 2007
- Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing RadiationPublished by Elsevier BV ,2007
- The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionMolecular Cancer, 2007
- Repopulation of cancer cells during therapy: an important cause of treatment failureNature Reviews Cancer, 2005
- Applying the principles of stem-cell biology to cancerNature Reviews Cancer, 2003
- Involvement of H2AX in the DNA Damage and Repair ResponseCancer Biology & Therapy, 2003
- Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitroInternational Journal of Radiation Oncology*Biology*Physics, 1994